Doyle Mittie bought AVTX
August 10, 2026 · Form 4 insider transaction
Doyle Mittie bought 679 shares of Avalo Therapeutics, Inc. at $8.04 per share, a transaction worth $5.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
679
Price
$8.04
Total value
$5.5K
InsiderDoyle Mittie
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 10, 2026
Filing dateAugust 12, 2026
Shares owned after52,455
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025.